FGF19 and fatty liver disease: Similar to the aggravation of liver steatosis, mRNA expression levels of genes associated with lipid synthesis, lipid transport and inflammation were increased in the liver of FGF19-treated Piezo1ΔIEC mice (Fig. 4G-I).